Endocrinology & Diabetes

Gestational Diabetes & Maternal-Fetal Endocrinology

Gestational diabetes mellitus (GDM) affects maternal and fetal outcomes in profound ways, and this track examines its pathophysiology, screening methods, and clinical management strategies. Experts will discuss insulin resistance in pregnancy, placental hormone interactions, genetic predispositions, and metabolic adaptations that can predispose women to glucose intolerance. The track also highlights global variability in screening practices, risk prediction models, and the evolving debate on universal versus selective testing. Attendees will learn about personalized nutrition therapies, safe pharmacological options, and emerging digital tools for improving glycemic control during pregnancy.

The maternal-fetal component explores how maternal metabolic status influences fetal development, birth outcomes, and long-term child health, including risks for obesity, insulin resistance, and Type 2 diabetes later in life. Presentations will cover fetal monitoring, growth assessment, and prevention of complications such as preeclampsia, macrosomia, and postpartum metabolic decline. Long-term management strategies for women with prior GDM—including postpartum screening and preventive interventions—will be emphasized. This track equips clinicians with evidence-based frameworks to deliver comprehensive care across preconception, pregnancy, and postpartum phases.